HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roy F Riascos Selected Research

Roy F Riascos Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 10/2013
2Glioma (Gliomas)
09/2022 - 01/2018
2Ischemic Stroke
01/2022 - 01/2021
2Infarction (Infarctions)
01/2022 - 01/2021
2Stroke (Strokes)
01/2021 - 01/2020
1Lung Neoplasms (Lung Cancer)
12/2023
1Brain Ischemia (Cerebral Ischemia)
01/2022
1Cerebral Infarction
01/2021
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2020
1Papilledema
01/2020
1Refractive Errors (Refractive Error)
01/2020
1Neurofibroma
12/2018
1Opportunistic Infections (Opportunistic Infection)
10/2014

Drug/Important Bio-Agent (IBA)

2alpha-hydroxyglutarateIBA
09/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
09/2022 - 01/2021
2Cytidine Triphosphate (CTP)IBA
01/2022 - 01/2020
1Circulating Tumor DNAIBA
01/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021
1Retinaldehyde (Retinal)IBA
01/2020
1EverolimusFDA Link
12/2018
1Choline (Choline Chloride)IBA
01/2018
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2018
1Methionine (L-Methionine)FDA Link
01/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018

Therapy/Procedure

2Therapeutics
12/2023 - 10/2014
2Thrombectomy
01/2022 - 01/2021
1Punctures
01/2021
1Drug Therapy (Chemotherapy)
10/2013
1Radiotherapy
10/2013
1Central Venous Catheters
10/2013